News & Views
Issue No. 12, 2009
After a period of reorganization, we are pleased to announce that the Center for Research and Treatment of Down Syndrome here at Stanford is starting a new era. Co-directors Dr. Craig Garner, Dr. Heidi Feldman, and Dr. Craig Heller are transforming the Center into a place, where the discovery of therapeutic strategies for the improvement of cognition in Down syndrome is top priority. Read more about our mission in the message from the directors.
In line with our new leadership goals, we would like to inform you about some exciting research conducted at Stanford by Dr. Ahmad Salehi (above) and his collaborators. This research has revealed another potential therapeutic strategy to improve learning in a mouse model of Down syndrome. However, we would like to emphasize that these studies were done in a mouse model and more work is required before commencing clinical trials in humans. Check back soon for a fresh News & Views article about these findings.
